JP2025500335A5 - - Google Patents
Info
- Publication number
- JP2025500335A5 JP2025500335A5 JP2024537335A JP2024537335A JP2025500335A5 JP 2025500335 A5 JP2025500335 A5 JP 2025500335A5 JP 2024537335 A JP2024537335 A JP 2024537335A JP 2024537335 A JP2024537335 A JP 2024537335A JP 2025500335 A5 JP2025500335 A5 JP 2025500335A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21216561 | 2021-12-21 | ||
| EP21216561.7 | 2021-12-21 | ||
| PCT/EP2022/086915 WO2023118087A1 (en) | 2021-12-21 | 2022-12-20 | Antisense oligonucleotides targeting unc13a |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025500335A JP2025500335A (ja) | 2025-01-09 |
| JPWO2023118087A5 JPWO2023118087A5 (https=) | 2026-01-06 |
| JP2025500335A5 true JP2025500335A5 (https=) | 2026-01-06 |
Family
ID=79018929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537335A Pending JP2025500335A (ja) | 2021-12-21 | 2022-12-20 | Ｕｎｃ１３ａを標的とするアンチセンスオリゴヌクレオチド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240327845A1 (https=) |
| EP (1) | EP4453207A1 (https=) |
| JP (1) | JP2025500335A (https=) |
| CN (1) | CN118974254A (https=) |
| WO (1) | WO2023118087A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2603454A (en) | 2020-12-09 | 2022-08-10 | Ucl Business Ltd | Novel therapeutics for the treatment of neurodegenerative disorders |
| CA3227115A1 (en) | 2021-07-21 | 2023-01-26 | Wen-Hsuan Chang | Unc13a antisense oligonucleotides |
| AU2023356317A1 (en) * | 2022-10-05 | 2025-05-15 | Trace Neuroscience, Inc. | Unc13a antisense oligonucleotides and uses thereof |
| WO2025068363A1 (en) * | 2023-09-29 | 2025-04-03 | F. Hoffmann-La Roche Ag | Peptide biomarker |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016528873A (ja) * | 2012-05-16 | 2016-09-23 | ラナ セラピューティクス インコーポレイテッド | 遺伝子発現を調節するための組成物及び方法 |
| WO2022018187A1 (en) * | 2020-07-23 | 2022-01-27 | F. Hoffmann-La Roche Ag | Oligonucleotides targeting rna binding protein sites |
| GB2603454A (en) * | 2020-12-09 | 2022-08-10 | Ucl Business Ltd | Novel therapeutics for the treatment of neurodegenerative disorders |
| AU2022255175A1 (en) * | 2021-04-06 | 2023-11-23 | Trace Neuroscience, Inc. | Compositions and methods for treating tdp-43 proteinopathy |
| WO2022246251A2 (en) * | 2021-05-21 | 2022-11-24 | Ionis Pharmaceuticals, Inc. | Compounds for modulating unc13a expression |
| CA3227115A1 (en) * | 2021-07-21 | 2023-01-26 | Wen-Hsuan Chang | Unc13a antisense oligonucleotides |
-
2022
- 2022-12-20 CN CN202280083648.2A patent/CN118974254A/zh active Pending
- 2022-12-20 EP EP22843158.1A patent/EP4453207A1/en active Pending
- 2022-12-20 WO PCT/EP2022/086915 patent/WO2023118087A1/en not_active Ceased
- 2022-12-20 JP JP2024537335A patent/JP2025500335A/ja active Pending
-
2024
- 2024-06-18 US US18/746,978 patent/US20240327845A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024513237A5 (https=) | ||
| JP2024520205A5 (https=) | ||
| JP2025500335A5 (https=) | ||
| CL2025003878A1 (es) | Sistemas de generación de energía a partir de fuentes geotérmicas y métodos de operación y construcción de los mismos. | |
| BR102023009641A2 (https=) | ||
| BY13169U (https=) | ||
| BY13175U (https=) | ||
| CN307049732S (https=) | ||
| CN307049582S (https=) | ||
| CN307049438S (https=) | ||
| CN307048206S (https=) | ||
| CN307048117S (https=) | ||
| CN307047333S (https=) | ||
| CN307047014S (https=) | ||
| CN307046041S (https=) | ||
| CN307045969S (https=) | ||
| CN307045515S (https=) | ||
| CN307044824S (https=) | ||
| BY13162U (https=) | ||
| BY13176U (https=) | ||
| BY13163U (https=) | ||
| BY13174U (https=) | ||
| BY13172U (https=) | ||
| BY13170U (https=) | ||
| BY13168U (https=) |